Facebook Twitter RSS Feed

You are here

Vascular & Endovascular

 - operation, operating room, surgery, intervention

A combination of directional atherectomy and embolitic protection filter to treat calcification in peripheral artery disease (PAD) patients showed a 97.2 percent success rate, according to a study published Aug. 1 in Catheterization and Cardiovascular Interventions.

 - blood, clot, vein, platelet

Researchers are asking if physicians still are on a learning curve when it comes to catheter-directed thrombolysis for proximal deep vein thrombosis (DVT) patients after noting no improvements over anticoagulant therapy in a study published July 21 in JAMA: Internal Medicine.

 - financial, graph, chart, upward

Stroke patients may be at a greater risk for post-surgical complications, particularly when they had a stroke less than three months prior to surgery, according to a study published July 16 in JAMA

 - equality

The incidence and mortality rates of stroke decreased for elderly men, women, blacks and whites over time for participants in the Atherosclerosis Risk in Communities group, a study published July 16 in JAMA showed. But for younger adults, the incidence trend didn’t carry through.

 - lower arrow

Incidence of ischemic stroke in patients aged 65 and older decreased by 41 percent between 1988 and 2008, according to data published in the July issue of the American Journal of Medicine. Hemorrhagic stroke decreased 16 percent in the same time period.


More Stories

30-day ECG monitoring spots candidates for anticoagulation

Prolonged electrocardiographic (ECG) monitoring in patients with cryptogenic stroke improved the detection of atrial fibrillation by a factor of five compared with standard 24-hour monitoring, results published June 26 in the New England Journal of Medicine showed. Detection changed anticoagulation treatment as well.

Male, elderly & 100+ cigarette history? That’s enough for USPSTF

Updated recommendations from the U.S. Preventive Services Task Force (USPSTF) call for screening male smokers ages 65 and older for abdominal aortic aneurysm.

FDA requires thromboembolism warning on testosterone products

Manufacturers of testosterone products will need to add a general warning about the risk of deep vein thrombosis and pulmonary embolism in their labeling, the FDA ruled. The warning is in addition to labeling that highlights thromboembolism as a possible consequence of polycythemia.

Thrombolysis for pulmonary embolism may lower mortality but raise bleeding risks

Compared with anticoagulant therapy, thrombolysis appears to have a lower mortality risk and lower risk of recurrent pulmonary embolism, but it does not come without risks of its own, a study published online June 17 in JAMA determined.

Length of stay, prior hospitalization foreshadow 30-day stroke readmissions

Clinicians with stroke patients, take note: A history of repeated hospitalizations before, a long stay in the hospital after and a higher National Institutes of Health Stroke Score may increase the risk of a patient returning within 30 days.

FDA panel votes in favor of drug-coated balloon for PAD

An FDA advisory panel voted unanimously in favor of approval for a drug-coated balloon to treat patients with peripheral artery disease (PAD). The first-of-its-kind device is indicated for use in the femoropopliteal arteries.

Despite more complications, women on par with men after PAD interventions

Women diagnosed with peripheral artery disease (PAD) were more likely to experience complications during peripheral vascular interventions than male counterparts, a study published June 17 in the Journal of the American College of Cardiology found. Nonetheless, both sexes had similar rates of procedural success.

69% of hospitals exceed average mortality risk for carotid artery stenting

About two in three hospitals certified by Medicare to provide carotid artery stenting (CAS) procedures had higher than average risks for mortality over a two-year period. These findings, published online June 3 in Circulation: Cardiovascular Quality and Outcomes, outline a way to review hospitals to determine which require more scrutiny prior to recertification.

Obesity offers no survival edge and poses earlier stroke risk

Stroke survival rates in obese and overweight patients may not be as paradoxical as earlier studies indicate. Researchers in Denmark suggested in a study published June 2 in JAMA Neurology that it might be a combination of comorbid conditions, severity and selection bias.

Deal lets Volcano add PAD device to its portfolio

Volcano will pay up to $130 million to acquire AtheroMed, giving Volcano access to a recently FDA-approved treatment for peripheral artery disease (PAD).

FDA gives PE ultrasound device a green light

The FDA cleared an ultrasound-based infusion technology as a treatment for pulmonary embolism (PE). According to EKOS Corp., its EcoSonic system is the sole minimally invasive endovascular therapy on the market.

MRI algorithm may ID stroke patients at risk of major bleeding

Physicians treating ischemic stroke one day may be able to determine patients’ risk for developing severe intracranial bleeding using an algorithm applied to standard MRI scans.

DIY PAD therapy: Home-based exercise program improves mobility

Peripheral artery disease (PAD) patients may see long-term, improved mobility and endurance with an exercise program that they can do at home. Participants saw a sustained improvement over baseline at 12 months, increasing their six-minute walk distance by about a third of a football playing field.

Boston Scientific snags Bayer’s peripheral unit for $415M

Boston Scientific will buy the interventional device division at Bayer AG for $415 million. The acquisition will let Boston Scientific widen its portfolio of technologies used to treat coronary and peripheral vascular disease.

Revised guidelines help reduce risk of recurrent strokes

Revised guidelines for the prevention of future stroke for survivors of a stroke or transient ischemic attack (TIA) align with other guidelines and provide additional sections based on new insights on risk factors.

Target: Stroke hits a bull’s eye with timely care, improved outcomes

A pre-post analysis of a national stroke initiative found patients were more likely to receive timely treatment and have better outcomes after the launch of the quality improvement program. The results were published in the April 23/30 issue of JAMA.

Covidien recalls embolization, retrieval devices

Covidien is recalling some endovascular devices due to a coating defect.

Europeans call for trials akin to caliber of HTN-3

The European Society of Hypertension (ESH) is calling for rigorous trials on renal denervation as a therapy for patients with treatment-resistant hypertension in the wake of results presented in the failed SYMPLICITY HTN-3 clinical trial.

FDA widens indication for Pradaxa

The FDA approved dabigatran for the treatment of deep vein thrombosis and pulmonary embolism in certain patients.

Stroke after AVR may be more common than previously believed

The association between aortic valve replacements (AVR) and clinical strokes may be stronger than originally believed, data from a study published April 1 in Circulation suggest.